MyRisk with RiskScore ® is a powerful tool that evaluates 48 genes to help healthcare providers identify their patients’ risk of developing 11 different types of hereditary cancer. More than a test, MyRisk’s clear, actionable results are the foundation for personalized care plans that can be used to help patients make confident, informed decisions about their medical management. Know Your Risk. Plan for your Future.
MyRisk with RiskScore ® is a powerful tool that evaluates 48 genes to help healthcare providers identify their patients’ risk of developing 11 different types of hereditary cancer. More than a test, MyRisk’s clear, actionable results are the foundation for personalized care plans that can be used to help patients make confident, informed decisions about their medical management. Know Your Risk. Plan for your Future.
For patients with family history of certain cancers, hereditary cancer testing is the primary way to determine if they are at an increased risk of developing specific types of cancer. MyRisk with RiskScore evaluates 48 genes associated with hereditary cancer risk to identify genetic changes associated with an increased cancer risk. When combined with family history and other clinical factors, MyRisk with RiskScore provides each patient with a cancer risk assessment individualized to them.
The MyRisk Management Tool offers personalized guidance for patients and providers to work together to reduce risk of developing cancer or detect it at an earlier, more treatable stage.
Because of the precision science behind MyRisk, 53% of patients 2 qualify for a medical management change that may help lower cancer risk, as opposed to only 10% with other hereditary cancer tests.
As the only hereditary cancer test designed for patients of all ancestries, the RiskScore component of MyRisk gives patients both a five-year and lifetime risk estimate of developing breast cancer. This is calculated using a combination of clinical risk factors, family history, and unique genetic, ancestry-informed breast cancer risk markers.
Every MyRisk test report provides a personalized assessment of a patient’s hereditary cancer risk, providing healthcare providers and patients with clear information to make informed decisions about managing cancer risk.
MyRisk assesses patient risk beyond just positive or negative, offering the following results: Positive
Elevated
Negative
The MyRisk Management Tool offers personalized guidance for patients with a higher risk of cancer. These plans may include guidelines for increased surveillance, risk- reducing medications, and/or risk-reducing surgery.
Eligible patients will be provided with a RiskScore which gives a personalized estimate of their five-year and remaining lifetime risk for developing breast cancer, guiding more confident decisions in managing their breast cancer risk.
